A patient in 28-week gestation is receiving labetalol and magnesium sulfate for her pre-eclampsia treatment. On checking her BP you find that it is 86/56. The most likely cause of this finding is?

1. A

   False reading

2. B

   Accidental overdose of labetalol

3. C

   Magnesium sulphate toxicity

4. D

   Patient is anxious

Appeared in: NORCET -4 , 2023

Explanation

Listen in Hindi

• Labetalol is a potent antihypertensive medication used to manage high blood pressure in pre-eclampsia.
• Its primary mechanism is to lower blood pressure by blocking alpha and beta-adrenergic receptors.
• A blood pressure of 86/56 mmHg is a state of severe hypotension.
• In a patient receiving labetalol, such a drastic drop in blood pressure is most directly and logically attributed to an excessive dose or an exaggerated therapeutic effect of the drug.

Why Other Options Were Wrong

• Option A: While a false reading is always a possibility with any medical equipment, it is not the most likely cause in this clinical scenario. The patient is on a medication known to cause hypotension, making a true physiological event more probable and critical to consider first for patient safety.
• Option C: Magnesium sulfate is used for seizure prophylaxis, not primarily for blood pressure control. The classic initial signs of magnesium toxicity are neurological (loss of deep tendon reflexes) and respiratory (respiratory depression). Severe hypotension is a later and less specific sign of toxicity.
• Option D: Anxiety activates the sympathetic nervous system, leading to the release of catecholamines like adrenaline. This causes vasoconstriction and an increase in heart rate, which would raise blood pressure (hypertension), not cause hypotension.

Related Visual

• Visual 1: Table 1: Magnesium Sulfate Toxicity Levels - A table showing the serum magnesium levels and their corresponding clinical manifestations, from therapeutic range to toxic effects like loss of reflexes, respiratory depression, and cardiac arrest.
• Visual 2: Table 2: Key Nursing Interventions for Pre-eclampsia - A table outlining essential nursing actions such as monitoring BP, assessing deep tendon reflexes, monitoring respiratory rate, and having the antidote (calcium gluconate) available.

Clinical Relevance

• Nursing practice connection: Knowing Pharmacological management of pre-eclampsia and recognition of adverse drug effects helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
• Nurses must perform vigilant monitoring of vital signs, especially blood pressure, in patients receiving IV antihypertensives like labetalol to prevent iatrogenic hypotension.
• It is crucial to differentiate between the side effects of labetalol (hypotension) and the signs of magnesium sulfate toxicity (loss of reflexes, respiratory depression) as they require different interventions.
• What if? If the patient's primary symptom was a respiratory rate of 10 breaths per minute and absent patellar reflexes, the most likely cause would shift to magnesium sulfate toxicity, and the immediate nursing action would be to stop the magnesium infusion and prepare to administer calcium gluconate.

How to Approach the Question

• First, identify the key information in the clinical scenario: a pregnant patient with pre-eclampsia is receiving two specific drugs (labetalol and magnesium sulfate).
• Note the primary clinical finding: a blood pressure of 86/56 mmHg, which is severe hypotension.
• Recall or look up the primary actions and major side effects of the two medications being administered.
• Labetalol is an antihypertensive; its purpose is to lower blood pressure. An overdose would cause an exaggerated effect, i.e., severe hypotension.
• Magnesium sulfate is an anticonvulsant; its primary toxic effects are CNS and respiratory depression.
• Compare the patient's presenting sign (hypotension) with the known effects of the drugs. The hypotension is a direct and expected consequence of a labetalol overdose.

Concept Tested & Keywords

• Concept Tested: Pharmacological management of pre-eclampsia and recognition of adverse drug effects.
• Stem keywords: 28-week gestation, pre-eclampsia, labetalol, magnesium sulfate, BP 86/56
• Lead-in keywords: most likely cause
• Clinical cues: The patient is receiving two potent medications, labetalol (an antihypertensive) and magnesium sulfate (a CNS depressant).
• Clinical cues: The presenting sign is severe hypotension (BP 86/56), which is a direct, predictable effect of an antihypertensive overdose.

Question ID

QLzF7b2v8dNvKfpmrAPRKT

Copy ID